Study Title: A Phase II Study of Sotorasib (AMG 510) in Participants With Previously Treated Stage IV or Recurrent KRAS G12C Mutated Non Squamous Non Small Cell Lung Cancer (ECOG ACRIN LUNG MAP SUB STUDY)
For more information about the trial above please contact the study team: